Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Edaravone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101830852A reveals a cost-effective Edaravone synthesis route using phenylhydrazine hydrochloride, offering high purity and yield for pharmaceutical supply chains.
Novel process for Edaravone glucuronide offering superior yield and purity, enabling reliable supply for metabolic studies and API development.
Patent CN104326984A details solvent-free edaravone synthesis ensuring high purity and reduced impurities for reliable pharmaceutical intermediate supply chains.
Novel patent CN106316957A offers high-purity Edaravone impurity intermediate synthesis with mild conditions and reduced costs for pharmaceutical supply chains.
Patent CN102336710B reveals efficient synthesis route. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN111848517B details a novel continuous flow method for Edaravone. Achieve high purity >99% and safer manufacturing. Contact us for supply.
Patent CN110922360B reveals a continuous reactive distillation method for Edaravone, offering superior yield and cost reduction in pharmaceutical intermediate manufacturing.
Novel acid-catalyzed method for Edaravone production offers >99% purity and simplified purification, ensuring cost-effective supply for pharmaceutical manufacturers.
Patent CN113683566A details a novel solvent-free synthesis of Edaravone achieving >99% purity. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN101747390B details a high-yield route for edaravone glucuronide, offering significant cost reduction in API manufacturing and improved purity.
Patent CN103588709B reveals solvent-free Edaravone synthesis. High purity >98% yields ensure cost reduction in API manufacturing and supply chain stability.